Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens.

Breast Cancer Res · 2004 · PMC1064088 · PMID 15535858

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Two other randomized trials compared the second-generation AIs formestane and fadrozole with tamoxifen [ 3 , 4 ] and showed a trend toward superiority of the AIs over the antioestrogen, but this was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.